Functional expression cloning is a powerful strategy for identifying critical steps in biological pathways independently of prior assumptions. It is particularly suitable for the identification of molecules crucial to the control of apoptosis. Our screen for sequences suppressing T-cell apoptosis isolated a sequence antisense to fau (FinkelBiskis-Reilly murine sarcoma virus (FBR-MuSV)-associated ubiquitously expressed gene). The fox gene in FBR murine osteosarcoma virus is also antisense to fau and several reports have indicated that fau displays tumour suppressor and oncogenic properties in different contexts. Our observations indicate that the fau antisense sequence suppresses expression of endogenous fau mRNA and produces resistance to apoptosis induced both by the glucocorticoid analogue dexamethasone' by ultraviolet radiation, and by the anticancer drug cisplatin. In all cases, colony-forming ability is protected, indicating that fau affects the critical events prior to commitment to cell death. Overexpression of fau in the sense orientation induces cell death, which is inhibited both by Bcl-2 and by inhibition of caspases, in line with its proposed role in apoptosis.
Apoptosis is a tightly regulated physiological process, which is crucial to the control of many biological functions. It plays a central role in the physiology of the immune response, cellular differentiation, malignant transformation and in the development of degenerative diseases (Green and Evan, 2002; Rathmell and Thompson, 2002) . Active cell death by apoptosis is also crucial for cytotoxic therapy of various cancers (Williams, 1991; Ferreira et al., 2002; Rathmell and Thompson, 2002) . It has therefore become clear that improved understanding of the mechanism of apoptosis at the molecular level should lead to the identification of appropriate targets for drug therapy.
Despite the significant progress of the last decade, precise knowledge of the molecular pathways involved in apoptosis remains incomplete and potentially many critical genes remain to be identified. Recently, appreciation of the molecular complexity of the processes of apoptosis control and drug sensitivity has highlighted the advantages of functional strategies for identifying those molecules that act at controlling, that is, rate-limiting, steps.
Our research programme aims to identify novel genes involved in apoptosis using cDNA library functional expression cloning. One invaluable advantage of this approach is that it uses selection strategies that result in the identification of genes based entirely on their function, so that no prior knowledge of the gene sequence is assumed or required (Whitehead et al., 1995; Zannettino et al., 1996) . The identification of many molecules involved in lymphocyte function (Starr et al., 1997) , lymphomas and other cancers (Li et al., 1997; Lund et al., 2002; Mikkers et al., 2002; Suzuki et al., 2002) has highlighted the success of this approach. Notable successes have also been achieved by using this approach in identifying novel apoptosis controlling genes such as LUCA15/RBM5 novel tumour suppressor gene (Sutherland et al., 2000) , protein phosphatase 4 (Mourtada-Maarabouni et al., 2003) and vATPase subunit E (Anderson and . In this study, we report the isolation of fau (Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV)-associated ubiquitously expressed gene) by functional expression cloning and its identification as an apoptosis regulatory gene.
Our functional expression system comprised a retroviral cDNA library generated from the murine factordependent FDCP-1 cell line as the source of apoptosis regulators (Rayner and Gonda, 1994) , the W7.2 mouse thymoma cells (Danielsen et al., 1983) used as screening hosts and dexamethasone followed by g-radiation as the apoptotic stimuli. The host for retroviral infections W7.2c was a subclone of the W7.2 mouse thymoma cell line with a low frequency of spontaneous apoptosis (Mourtada-Maarabouni et al., 2003) . W7.2 cells have been used in many apoptosis studies, particularly for the study of dexamethasone-induced apoptosis.
W7.2 cells infected with the FDCP1 retroviral cDNA library (Mourtada-Maarabouni et al., 2003) were cultured for 6 days with 20 nM dexamethasone, followed by 500 cGy g-irradiation to induce apoptosis. These two stimuli were used consecutively to increase the likelihood of identifying genes that are involved in stages in the apoptotic pathways that are common to several stimuli, rather than being involved in a stimulusspecific stage of the pathway. These cultures were then grown in soft agar. In total, 18 colonies were eventually formed from the 10 6 retrovirally infected cells plated. Of these, 10 were picked and eight of these grew in liquid culture. Four colonies contained inserts demonstrating antiapoptotic activity when subcloned into pRUFneo. 2 colonies contained a partial cDNA for protein phosphatase 4 (Mourtada-Maarabouni et al., 2003) and two others, DG3.cd1 and DG3.cd3, contained sequences antisense to fau (Kas et al., 1992) . The insert contained in DG3.cd1 cells consists of a 254 bp fragment that is 100% homologous to the murine fau gene located on chromosome 19 (Casteels et al., 1995) , and it is present in the FDCP1 cDNA library retroviral library in the opposite orientation to the direction of fau transcription. The fau gene consists of five exons and the first exon is not translated. The DG3.cd1 sequence is antisense to 254 bp of the coding sequence of fau in exons 2-4 and to 15 bp in exon 5 (Figure 1 ). The fau gene is the cellular homologue of the fox gene in FBRMuSV (Van Beveren et al., 1984) , a virus that induces osteosarcoma in susceptible mice, and is also expressed in the opposite orientation to the fox gene. Interestingly, DG3.cd1 is 100% homologous to the fox gene in FBRMuSV, and is also expressed in the same orientation as the fox gene (i.e. antisense to fau).
The insert contained in colony DG3.cd1 (rfau) was amplified by PCR with Pfu proofreading polymerase, cloned into pCR-Blunt II-TOPO, subcloned into pRUFneo and reinfected into fresh W7.2c cells, referred to as DG3.ab4 21 clones. This allowed us to exclude the possibility that the apoptosis resistance observed originally was the result of a spontaneous mutation, rather than the expression of the insert. When apoptosis was induced by the corticosteroid analogue dexamethasone or by irradiation, cells infected with DG3.cd1-containing retrovirus were more resistant than controls and this effect of DG3.cd1 was investigated in detail below.
To investigate and confirm the antiapoptotic effects of rfau (DG3.cd1), the insert was directionally cloned in pcDNA3.1/V5-His TOPO. Following transfection of either pcDNA3.1 (empty vector) or pcDNA3.1-DG3.cd1 into W7.2c cells, stable clones were selected by growth in geneticin (G418). Five empty vector-and 10 DG3.cd1-transfected stable clones were then cultured in 96-well plates at 2 Â 10 5 cells/ml in the absence or presence of 50 nM dexamethasone, for up to 72 h. All DG3.cd1 stable clones demonstrated resistance to cell death compared to the empty vector-transfected clones, as demonstrated by nigrosin dye exclusion and MTS assay. As shown in Figure 2a and b, cells overexpressing DG3.cd1 (rfau) were 15-30% more viable than control cells transfected with vector only (pcDNA3.1). Long-term survival of these clones was also assessed by incubating at 371C in soft agar after 72 h exposure to dexamethasone. Results showed clearly that the colony-forming ability of these clones was significantly protected (Figure 2c) .
Overexpression of rfau also inhibited UV-induced apoptosis. rfau (DG3.cd1) and vector-only pcDNA3.1 clones were exposed to UV at 254 nm and 40 J/m 2 . Apoptosis was assessed 24 h after UV exposure, using a fluorescent caspase inhibitor fam-VAD-fmk, which allows the detection of active caspases in live cells. The
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TGGAAGTAGCAGGCCGCATGCTGGGAGGTAAAGTTCACGGTTCCCTGGCTCGGGCTGGAA 210 ************************************************************ Fau AAGTGAGAGGTCAGACTCCCAAGGTGGCCAAACAGGAAAAGAAGAAGAAGAAGACAGGCC 360 rDG3.cd1
AAGTGAGAGGTCAGACTCCCAAGGTGGCCAAACAGG------------------------246 ************************************ In order to evaluate the involvement of fau in apoptosis, the effects of several other cytotoxic agents were also examined. Cells transfected with rfau were not resistant to cell death induced by etoposide (100 ng/ml-1 mg/ml; Sigma), doxorubicin (Sigma) or anti-Fas antibody (Jo2 Pharmingen) (data not shown). However, rfau did produce significant protection against cell death induced by cisplatin (1 mg/ml; Sigma) ( Figure 4a ) and also provided striking protection from the loss of colony-forming ability caused by cisplatin ( Figure 4b ).
The resistance conferred by rfau to cell death induced by dexamethasone, UV and cisplatin, but the susceptibility to cell death induced by anti-Fas antibody suggests involvement in the intrinsic (mitochondrial) pathway of apoptosis, rather than the extrinsic (cell surface death receptor) pathway. The lack of protection from doxorubicin and etoposide may reflect the induction of cell death by additional mechanisms, such as mitotic catastrophe, which do not require the participation of the apoptotic pathway (e.g. Lock et al., 1996) .
We further examined whether the insert DG3.cd1 could be affecting apoptosis by altering the expression of fau. Northern blotting experiments were carried out on total RNA isolated from rfau (DG3.cd1)-transfected clones and control cells transfected with vector only. Northern blotting experiments using a hybridization probe complementary to part of cellular fau not found in the DG3.cd1 insert revealed that the endogenous fau RNA (600 bp) was expressed in all the clones (Figure 5a ). The bands observed were then quantified using a PhosphorImager (Bio-Rad). The results were averaged from three different experiments, and normalized to actin loading controls. Normalized fau expression was significantly reduced in rfau (DG3.cd1) clones ( Figure 5b ) and this reduction in fau expression was consistent between all clones.
The fau gene encodes a 133 aa protein (14 416 kDa), consisting of the 59 aa ribosomal protein S30 at the C-terminal fused with a 74 aa ubiquitin-like protein (FUBI). The S30 protein is cleaved post-translationally to be incorporated into the small ribosomal subunit. Western blotting using an antibody against the FUBI c b a Figure 2 rfau (DG3.cd1) overexpression inhibits dexamethasoneinduced cell death. Insert DG3.cd1 was directionally cloned into pcDNA3.1/V5-His TOPO (Invitrogen). PcDNA3.1 or pcDNA3.1-DG3.cd1 was electroporated into a subclone of the W7.2 mouse thymoma cell line W7.2c, as described previously (MourtadaMaarabouni et al., 2003) . Stable clones were established 24 h posttransfection, by soft agar cloning in Iscoves's modified Dulbecco's medium containing 2 mM glutamine (Sigma) supplemented with 20% heat-inactivated foetal bovine serum (FCS; Hyclone, UT, USA) in the presence of 1 mg/ml G418 (Sigma), and incubated at 371C in a humidified incubator for 2-3 weeks. Individual colonies were picked and expanded in RPMI medium containing 2 mM glutamine and 10% FCS and 1 mg/ml G418. Stable incorporation of the insert was verified by PCR on genomic DNA. Five empty vector-and 10 DG3.cd1-transfected stable clones were then cultured in 96-well plates at 2 Â 10 5 cells/ml in the absence or presence of 50 nM dexamethasone, for up to 72 h. (Nakamura et al., 1995) detected two bands at about 15 kDa, which were clearly downregulated in cells expressing rfau (Figure 6, lanes 4-7) , supporting the involvement of Fau in the effects observed in W7.2c cells containing pcDNA3.1-DG3.cd1. Since Fau itself is predicted to be approximately this size, the two bands could differ in posttranslational modifications or could represent the FUBI part of Fau ligated to another polypeptide (e.g. Nakamura and Tanigawa, 2003) .
The fau gene is ubiquitously expressed in different mouse and human tissues and its sequence is conserved between several species. Here, we report the observations that a sequence antisense to fau is able to inhibit apoptosis induced by dexamethasone, UV or cisplatin. We have also clearly demonstrated that expression of this antisense sequence downregulates fau mRNA and protein, and that downregulation of fau produced an obvious effect on cell survival. The suppressive capability of rfau (DG3.cd1) is likely to be the result of an antisense effect. The manipulation of gene expression by antisense oligonucleotides, full-length cDNA or cRNA constructs, which compliment the sequence of a target RNA, are well documented and used routinely to inhibit gene expression (Knee and Murphy, 1997) . The activity of exogenous antisense molecules has also been explained by various mechanisms including effects on transcription, nuclear processing, nuclear transport, mRNA stability and translation (Denhardt, 1992; Woolf et al., 1992) .
In order to confirm the proapoptotic role of Fau implied by the protective effects of the antisense sequence, rfau, further experiments were carried out to examine directly the effect of overexpression of fau, in the sense orientation, on W7.2c cells. Transfection of W7.2c cells with a plasmid expressing sense fau induced cell death, which was largely inhibited by the general caspase inhibitor z-VAD-fmk (e.g. Longthorne and Williams, 1997) , and was completely inhibited by cotransfection with a plasmid expressing bcl-2 (Figure 7 ). These observations on the cell death induced by fau in the sense orientation are entirely consistent with the antiapoptotic effects of the antisense sequence rfau initially observed.
Fau is the cellular homologue of the fox gene encoded in the FBR mouse sarcoma virus, originally isolated from a radiation-induced osteosarcoma (Finkel et al., 1976) , and the complete mouse fau cDNA is inversely inserted as the fox sequence in FBR-MuSV. Although the exact functions of fau are poorly understood, it is thought to play a role in ribosome biosynthesis and it has been suggested that its FUBI domain acts as a chaperone molecule to facilitate the incorporation of the 30S protein into ribosomes (Hochstrasser, 2000) . In addition, a number of pieces of evidence suggest that the fau gene may possess tumour suppressor and oncogenic activity in different situations. Expression of the fox sequence -antisense to the fau gene -is reported to increase the tumorigenicity of FBR-MuSV, providing evidence that fau might be acting as a tumour suppressor gene . Our observation of the role of Fau in the control of apoptosis suggests Figure 6 Analysis of effects of rfau by Western blotting. Wholecell lysates were prepared from W7.2c cells stably transfected with pcDNA3.1(À) in lanes 1-3 or pcDNA3.1-DG3.cd1 in lanes 4-7. Briefly, 10 6 cells were washed twice in PBS and resuspended in 50 ml cell lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% nonidet P40, 1 mM EDTA, 1 mM pepstatin, 10 mg/ml leupeptin, 1 mM PMSF). The cell suspension was then incubated on ice for 30 min, before centrifugation at 10 000 g for 10 min. Protein concentration in the supernatant was determined using the BioRad protein assay kit. Protein (50 mg) was then added to SDS-PAGE sample buffer (10% glycerol, 0.7 M b-mercaptoethanol, 3% SDS, 62 mM Tris-HCl, pH 6.8), boiled for 10 min and loaded onto a 10% polyacrylamide gel alongside a Rainbow molecular weight marker (Sigma). After electrophoresis, the gel was blotted onto a PVDF membrane (Bio-Rad). The membrane was blocked in blocking buffer (Tris-buffered saline plus Tween 20 (TTBS: 20 mM Tris-HCl, 500 mM NaCl (pH 7.5) plus Tween 20 0.05%; containing 5% bovine serum albumin) for 1 h. After washing with TTBS, the membrane was incubated overnight at 41C in the presence of the primary antibody, anti-PU1 (Nakamura et al., 1995 ; rabbit antibody against a synthetic peptide related to the ubiquitin-like motif of Fau, used at a dilution of 1 : 4000), followed by 1 h incubation in the presence of secondary antibody at room temperature. The secondary antibody was horseradish peroxidaseconjugated goat anti-rabbit IgG (Sigma; #A0545) used at a concentration of 1 : 10 000. Detection was carried out using an ECL chemiluminescence kit (Amersham). To verify equal loading, blots were stripped and reprobed with anti-b-actin antibody (Sigma; #A5441) a b Figure 5 rfau (DG3.cd1) reduces endogenous fau mRNA levels. (a) Northern analysis of fau of W7.2/pcDNA3.1 or W7.2/ pcDNA3.1-DG3.cd1. Total RNA from 10 7 W7.2 clones was isolated using Trizol (GIBCO BRL; #15596-026)) according to manufacturer's instructions. Total RNA (20 mg) was resolved by formaldehyde-containing 1% agarose gel electrophoresis, blotted onto a nylon membrane (Hybond-N, Amersham Pharmacia) and immobilized by UV crosslinking (Bio-Rad, crosslinker). Hybridization was performed in ULTRAhyb buffer (Ambion) at 421C with fau probe. Primers used to produce this probe were Fau-fwd (5 0 -G AAGACAGGCCGGGCCAAGAG) and Fau-rev (5 0 -TTTTTGT CTGGACACAGTGG), and the radioactive labelling of the probe was carried out by random primer-directed synthesis using the DNA Labelling kit (Amersham Pharmacia) and [a-32 P]dCTP (3000 Ci/mmol, ICN). Unincorporated [a-32 P]dCTP was removed from the labelled DNA probe using a NICK column containing Sephadex G-50 (Amersham Pharmacia). Radioactivity was quantitated using a PhosphorImager (Bio-Rad). To check the amount of RNA loaded on all lanes, blots were stripped by boiling in 0.5% SDS and rehybridized with a mouse b-actin probe. A representative photograph is shown (lanes 1-3 W7.2/pcDNA3.1; lanes 4-6 W7.2/ pcDNA3.1-DG3.cd1). (b) Ratios of normalized Fau to b-actin. The plotted data were averaged from five independent clones and from two independent experiments7s.e. *Po0.01 compared to vector only Downregulation of fau suppresses T-cell apoptosis M Mourtada-Maarabouni et al that the effects of the identical viral fox sequence on tumorigenicity may well involve a novel mechanismthe regulation of apoptosis. Overexpression of fau is also reported to confer resistance to the human carcinogen arsenite in Chinese hamster V79 cells (Rossman and Wang, 1999) . On the other hand, overexpression of fau itself is reported to transform human osteogenic sarcoma cells to anchorage independence (Rossman et al., 2003) . Further studies have shown that the FUBI domain of Fau possesses the transforming activity, whereas expressing the S30 domain conferred arsenite resistance. (Rossman et al., 2003) . Other functions have been assigned to Fau as an immunosuppressor (Nakamura et al., 1995) and as an antimicrobial protein, ubiquicidin, isolated from the cytosolic fraction of an interferon-g-treated macrophage cell line (Hiemstra et al., 1999) .
In addition to its reported functions, we have presented here a series of observations that strongly implicates fau in the regulation of apoptosis. The Expression of fau in the sense orientation causes cell death, which can be inhibited by Bcl-2 and z-VAD-fmk. Using electroporation (BioRad; 260 V, 960 mF), W7.2 cells (10 7 cells/transfection) were transfected either with 5 mg pEGFP-C1 (Column 1) (Clonetch; Cat. #6084-1; Gene Accession #U55763), with 5 mg pEGFP-C1 together with 20 mg pCMV-SPORT6-fau (Columns 2 and 3; Column 3 -also incubated with z-VAD-fmk)) (Accession #BI080276) or with pEGFP-C1 (5 mg) and pCMV-SPORT6-fau (20 mg) together with 20 mg SFFV-neo-bcl2 (Column 4) (Lam et al., 1994 ; donated by Dr David Askew) (transfection efficiency 50-60%). Cells were either (a) maintained as polyclonal population in the presence of G418 (1 mg/ml) to ensure elimination of untransfected cells, and the viability of transfected cells was assessed by vital dye staining using 0.2% nigrosin, 10 days after transfection, or (b) cells were cloned in soft agar in the presence of 1 mg/ml G418 to assess their colony-forming ability. Incubating fau-transfected cells in the continuous presence of 50 mM z-VAD-fmk (Z-Val-Ala-Asp.fmk; Enzyme Systems products, Dublin, CA, USA) (Column 3) partially reversed the effects of fau, and cotransfection with bcl-2 expression plasmid sffv-neo-bcl2 (Column 4) totally reversed the effects of fau. Photographs of representative plates are shown in (c) Downregulation of fau suppresses T-cell apoptosis M Mourtada-Maarabouni et al amino-terminal part of Fau shows a strong homology to ubiquitin, a 76 aa multifunctional cellular protein, and contains the Gly-Gly dipeptide (Monia et al., 1990) , a conserved feature of ubiquitin and ubiquitin-like proteins, which is required for protein conjugation with the e-amino groups of lysine side chains on the acceptor proteins. Modification of proteins by the covalent attachment of ubiquitin, that is, ubiquitination, is known to mark proteins for degradation by the 26S proteasome (reviewed by Jentsch and Pyrowolakis, 2000) . Several ubiquitin-like proteins have been identified (Jentsch and Pyrowolakis, 2000; Yeh et al., 2000) , and these proteins are reported to be involved in a number of cellular processes, including protein sorting and degradation, cell-cycle progression, DNA repair and apoptosis (Jentsch and Pyrowolakis, 2000; Yeh et al., 2000) . A well-characterized member of this family, SUMO1, has been shown to modify a number of oncoproteins like p53 and c-jun, altering their levels of activity (Sampson et al., 2001) . Another interesting member of the family is the FAT10 protein, formerly called dibiquitin. FAT10 is an 18 kDa protein consisting of two ubiquitin-like domains combined by a short linker, with an N-terminal domain possessing 52% homology to the FUBI domain of Fau (Fan et al., 1996; Rossman et al., 2003) . FAT10 is reported to induce apoptosis in mouse fibroblasts and its expression is reported to be induced by tumour necrosis factor a (Raasi et al., 2001) . FAT10 has also been implicated in cell-cycle regulation, and it has been suggested that it may be a key modulator of tumorigenesis (Liu et al., 1999) . Recently, FAT10 expression was reported to be consistently upregulated in hepatocellular carcinoma and cancers of the gastrointestinal tract and the female reproductive systems (Lee et al., 2003) . In recent years, many reports of ubiquitination of key apoptosis regulatory proteins molecules have characterized ubiquitin as an essential regulatory modification targeting proteins for proteasomal degradation. Ubiquitin expression is reported to increase during apoptosis in the intersegmental muscle of insects (Schwartz et al., 1990) and mature murine and human lymphocytes (Roy et al., 1992; Delic et al., 1993) . Ubiquitination of Bcl-2 proteins is also known to target degradation of either pro-or antiapoptotic family members (Dimmeler et al., 1999; Breitschopf et al., 2000; Li and Dou, 2000) . In addition, the regulation of the level and activity of p53 and the activation of NF-kB1 involves changes in ubiquitination (Palombella et al., 1994; Mayo and Donner, 2002) . The presence of the C-terminal double glycine motif on the FUBI domain suggests that this domain is capable of forming conjugates with other proteins. Fau might also be affecting some ubiquitin-like proteins involved in apoptosis, such as FAT10, and identification of the putative target proteins of Fau may help elucidate its role in apoptosis. The recent identification of FUBI covalently bound to Bcl-G, a member of the Bcl-2 family of apoptosis control proteins (Nakamura and Tanigawa, 2003), suggests one attractive possible mechanism for apoptosis regulation by Fau. Finally, It is important to note that the human fau gene has been assigned to 11q13, a crucially important chromosomal locus that contains several oncogenes, namely BCL1, CCND1, encoding the cell-cycle regulatory gene cyclin D1, and EMS1, encoding the filamentous actin binding protein and c-Src substrate cortactin, TAOS1 (tumour-amplified and overexpressed sequence 1), as well as the putative tumour suppressor genes MEN1 (multiple endocrine neoplasia type 1; Chandrasekharappa et al., 1997, ST3 (suppression of tumorigenic) (Wlodarska et al., 1993; Huang et al., 2002; Katoh and Katoh, 2003; Ormandy et al., 2003) and BRMS1 (Seraj et al., 2000) . Kas et al. (1993) reported the exclusion of Fau as the MEN1 tumour suppressor gene and another apoptosis controlling gene, requiem, is encoded close to fau at 11q13 (Gabig et al., 1998) . Amplification and rearrangement of 11q13 is a common event in human cancer and has been reported in about 45% of head and neck carcinomas and in other cancers including oesophageal, breast, liver, lung and bladder cancer (Lammie and Peters, 1991; Kas et al., 1993; Katoh and Katoh, 2003; Ormandy et al., 2003) . The role of fau in apoptosis regulation, a critically important process during oncogenesis, therefore makes it particularly important to examine if there is an association between fau expression and the cancers associated with this subregion of chromosome 11.
